Previously, we found that CMAS KO in a murine model resulted in enhanced infiltration of CD4+ and CD8+ T cells within the tumor microenvironment of pancreatic ductal carcinoma and improved survival outcomes (14). The gene discussed is CD8A; the disease is pancreatic ductal adenocarcinoma.